Combination immune checkpoint blockade as an effective therapy for mesothelioma

Combination immune checkpoint blockade as an effective therapy for mesothelioma

Mesothelioma is an aggressive asbestos induced cancer with extremely poor prognosis and limited treatment options. Immune checkpoint blockade (ICPB) has demonstrated effective therapy in melanoma and is now being applied to other cancers, including mesothelioma. However, the efficacy of ICPB and whi...

Full description

Bibliographic Details
Main Authors: Vanessa S. Fear, Caitlin Tilsed, Jonathan Chee, Catherine A. Forbes, Thomas Casey, Jessica N. Solin, Sally M. Lansley, Willem Joost Lesterhuis, Ian M. Dick, Anna K Nowak, Bruce W. Robinson, Richard A. Lake, Scott A. Fisher
Format: Article
Language:English
Published: Taylor & Francis Group 2018-10-01
Series:OncoImmunology
Subjects:
mesothelioma
immune checkpoint blockade
immunotherapy
anti-ctla-4
anti-ox40
Online Access:http://dx.doi.org/10.1080/2162402X.2018.1494111

Internet

http://dx.doi.org/10.1080/2162402X.2018.1494111

Similar Items